Results 131 to 140 of about 85,339 (226)

Improved Preoperative Diagnosis of Medullary Thyroid Carcinoma Using Dual-Mode Ultrasound Radiomics. [PDF]

Cancers (Basel)
Gao L, Li N, Xia Y, Ma L, An Y, Ji J, Gu J, Zhang D, Luo N, Cao Y, Fan Y, Jiang Y.   +11 more
europepmc   +1 more source

Real‐World Effectiveness and 12‐Month Persistence of a Semaglutide‐Supported Digital Weight‐Loss Service: A Retrospective Cohort Study in Germany

Diabetes, Obesity and Metabolism, Volume 28, Issue 8, Page 6985-6996, August 2026.
ABSTRACT Aim To evaluate the 12‐month effectiveness and patient persistence of a semaglutide‐supported digital weight‐loss service (DWLS) in a real‐world German cohort. Methods This retrospective study analysed 4535 patients who initiated the Juniper Germany DWLS. Primary endpoints included 12‐month medication and data submission adherence (receiving ≥ 
Louis Talay, Jason Hom, Marilyn Tan, Neera Ahuja   +3 more
wiley   +1 more source

Clinical characteristics and prognosis of familial non-medullary thyroid carcinoma: a retrospective study of 98 families. [PDF]

World J Surg Oncol
Yang G, Zhang Y, Xu T, Fan Y, Ran Y, Li P, Zheng X, Wei T.   +7 more
europepmc   +1 more source

FOXA1 is a highly sensitive diagnostic marker for prostate cancer including small cell carcinoma of the prostate

Histopathology, Volume 89, Issue 2, Page 240-250, August 2026.
FOXA1 is a highly sensitive diagnostic marker for prostate cancer. Besides prostatic adenocarcinoma, it is also expressed in 57%–80% of metastatic or primary prostatic small cell carcinomas, which lose traditional prostatic markers including NKX3.1. Although it is less specific than NKX3.1, it can serve as a valuable adjunct for confirming prostatic ...
Jianping Zhao, Jun Yao, Hossein Hosseini, Ezra Baraban, Ruihe Lin, Charles C. Guo, Lei Huo, Wei Lu, Khaja Khan, Shufang Wang, Luisa Maren Solis Soto, Qingqing Ding   +11 more
wiley   +1 more source

Combined Detection of Preoperative Serum Calcitonin and Carcinoembryonic Antigen in Medullary Thyroid Carcinoma: A Retrospective Multicenter Cohort Study. [PDF]

Health Care Sci
Yang Y, He Y, Lin B, Zheng Y, Deng X, Chen W, Ke Z, Qiu Y, Hong Y, Zhang J, Dong G, Qiao S, Xin Z, Li X, Xu T, Chen W, Chen X, Hou Y, Lai F, Long J, Zhang Z, Xu X, Liu Y.   +22 more
europepmc   +1 more source

Catecholamines Activate a Tumour Progression Program in Differentiated Tumour Hepatocytes

Liver International, Volume 46, Issue 8, August 2026.
ABSTRACT Background and Aims The sympathetic nervous system is involved in the progression and aggressiveness of several cancers, including hepatocellular carcinoma (HCC). However, the specific effects of sympathetic innervation and catecholamines on tumour hepatocyte behaviour remain poorly understood.
Elise Lelou, Claudine Rauch, Hélène Dubois‐Pot‐Schneider, Marjorie Dufresne, Abolfazl Zekri Yazdi, Maelle Guillout, Luis Cano, Lise Desquilles, Nicolas Nesseler, Marc Bourgeois, Claude Bendavid, Julie Massart, Orlando Musso, Anne Corlu, Caroline Aninat   +14 more
wiley   +1 more source

Real-world clinical responses to selpercatinib in RET M918T-mutant medullary thyroid carcinoma. [PDF]

Discov Oncol
Ökten IN, Baydaş T.
europepmc   +1 more source

The Roles of MicroRNAs, Oncogenes, and Tumor Suppressor Gene Molecular Subtypes of Breast Cancer: Therapeutic Potential of Pharmaceutical and Natural Products. [PDF]

Int J Breast Cancer
Jaman MS, Maniruzzaman M, Bhuiyan MRH, Haque MS.   +3 more
europepmc   +1 more source

Familial Status Modulates the Stability of Excellent Response in Non-Medullary Thyroid Carcinoma: Implications for Tailored Surveillance. [PDF]

Cancers (Basel)
Valerio L, Sagnella A, Maino F, Mattii E, Cartocci A, Castagna MG.   +5 more
europepmc   +1 more source

Medullary Thyroid Carcinoma in a Horse [PDF]

Veterinary Pathology, 1986
M A, van der Velden, H, Meulenaar
openaire   +2 more sources